Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

Nov. 16, 1998

Celecoxib studies continue to generate impressive efficacy and safety data

Nov. 16, 1998

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Nov. 16, 1998

Boston Life Sciences presents amiprilose phase III data at ACR meeting

Nov. 16, 1998

rHuIL-4 safe in patients with RA; efficacy studies are indicated

Nov. 16, 1998

Nonantimicrobial tetracycline exerts antiarthritic effects via upregulation of IL-10 production

Nov. 16, 1998

Leo's oral vitamin D analogue induces regression, inhibits tumor growth in hepatocellular carcinoma

Nov. 13, 1998

Mizoribine evaluated in children with frequently relapsing nephrotic syndrome

Nov. 13, 1998

SB team attempts to identify the source of antiparkinsonian activity of SKF-83959

Nov. 13, 1998

New cytokine modulator from Schering-Plough is active in models of endotoxemia

Nov. 13, 1998

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...